Your browser doesn't support javascript.
loading
Target Actionability Review: a systematic evaluation of replication stress as a therapeutic target for paediatric solid malignancies.
Keller, Kaylee M; Krausert, Sonja; Gopisetty, Apurva; Luedtke, Dan; Koster, Jan; Schubert, Nil A; Rodríguez, Ana; van Hooff, Sander R; Stichel, Damian; Dolman, M Emmy M; Vassal, Gilles; Pfister, Stefan M; Caron, Hubert N; Stancato, Louis F; Molenaar, Jan J; Jäger, Natalie; Kool, Marcel.
Afiliação
  • Keller KM; Princess Máxima Center for Paediatric Oncology, Utrecht, the Netherlands.
  • Krausert S; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Gopisetty A; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Luedtke D; Eli Lilly and Company, Indianapolis, IN, USA.
  • Koster J; Department of Oncogenomics, Amsterdam University Medical Centre, Amsterdam, the Netherlands.
  • Schubert NA; Princess Máxima Center for Paediatric Oncology, Utrecht, the Netherlands.
  • Rodríguez A; Hoffman-La Roche, Basel, Switzerland.
  • van Hooff SR; Princess Máxima Center for Paediatric Oncology, Utrecht, the Netherlands.
  • Stichel D; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Dolman MEM; Princess Máxima Center for Paediatric Oncology, Utrecht, the Netherlands; Children's Cancer Institute, Lowy Cancer Centre, UNSW Sydney, Kensington, NSW, Australia; School of Women's and Children's Health, Faculty of Medicine, UNSW Sydney, NSW Australia.
  • Vassal G; Department of Clinical Research, Gustave Roussy, Villejuif, France.
  • Pfister SM; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany; Department of Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Caron HN; Hoffman-La Roche, Basel, Switzerland.
  • Stancato LF; Eli Lilly and Company, Indianapolis, IN, USA.
  • Molenaar JJ; Princess Máxima Center for Paediatric Oncology, Utrecht, the Netherlands.
  • Jäger N; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Kool M; Princess Máxima Center for Paediatric Oncology, Utrecht, the Netherlands; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany. Electronic address: m.kool@kitz-heide
Eur J Cancer ; 162: 107-117, 2022 02.
Article em En | MEDLINE | ID: mdl-34963094
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Neoplasias Cerebelares / Meduloblastoma Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Neoplasias Cerebelares / Meduloblastoma Idioma: En Ano de publicação: 2022 Tipo de documento: Article